Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin in Metformin Intolerant Obese Women With PCOS
NCT03122041Phase 4Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Aug 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of sitagliptin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Homeostasis model assessment for beta cell function at 12 weeks. Started Aug 2016; status: completed.
02
Drugs
sitagliptin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03122041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03122041.